Long-term investor

Cancer Treatment Stocks @etcancermed

Investor on eToro since 2022-01-31, 1,152 copiers, risk score 5 of 10, 84% of 95 trades profitable over the last year. Positions are the venue's reported weights; dollar sizes are not published.

Record

  • Tracked since 2022-01-31 (1704 days), 64 trades recorded
  • Returns: week n/a · month +0.9% · 90 days +9.3% · 6 months +30.3% · 1 year +60.3% · all +114.8%
  • Max drawdown -20.2% · Sharpe 0.64 · win rate 79% · data quality High
  • Source: eToro (public profiles) (eToro public profiles; typical delay 1 hours)

Open positions

  • RVMD · 7.6% · long
  • GH · 5.6% · long
  • NEO.US · 5.0% · long
  • ADPT · 4.6% · long
  • SRRK · 3.9% · long
  • ILMN · 3.5% · long
  • HALO · 3.5% · long
  • MRK · 3.5% · long
  • KURA · 3.4% · long
  • JNJ · 3.2% · long
  • LGND · 3.2% · long
  • GILD · 3.2% · long

Copy on paper, free More traders How copying works

Past performance does not predict future results. Copy trading can lose money. Meror is software, not an adviser.

Krishan Thushyanthan, operating as HEBAANDCO
303 Bristol Rd W, Mississauga, ON L5R 2H1, Canada · support@meror.ca
Explore traders·Prediction markets·Styles·Data sources·Pricing·FAQ·About·Contact
Terms·Risk disclosure·Privacy·Billing terms·Copy authorization·Cookie settings

Meror is software, not a broker, dealer or adviser, and is not registered with the Ontario Securities Commission, any Canadian securities regulator or the U.S. SEC. Copy trading can lose money, including the whole amount copied. Meror never holds customer funds; past performance does not predict future results. Payments are processed by Stripe.

Meror is software, not a broker-dealer, exchange or investment adviser, and never holds customer funds. Copy trading can lose money; past performance does not predict future results. Payments are processed by Stripe.